Kirk D. Denicoff

11.2k citations

74 papers · 8.5k indexed · 1 hit paper · h-index 47

Biological Psychiatry top 0.2%
- Tryptophan and brain disorders 7
Psychiatry and Mental health top 0.05%
- Bipolar Disorder and Treatment 57
- Electroconvulsive Therapy Studies 21
- Schizophrenia research and treatment 16
- Epilepsy research and treatment 6
Behavioral Neuroscience top 1%
Speech and Hearing top 0.2%
- Adolescent and Pediatric Healthcare 10
Clinical Psychology top 1%
Pediatrics, Perinatology and Child Health
- Pharmacological Effects and Toxicity Studies 13
Pharmacology
- Treatment of Major Depression 10

Co-authors: Gabriele S. Leverich Robert M. Post Mark A. Frye Ralph Kupka Willem A. Nolen Lori L. Altshuler Susan L. McElroy Paul E. Keck
Cited by: Biological Psychiatry Psychiatry and Mental health Behavioral Neuroscience
Partner nations: United States Netherlands Czechia

In The Last Decade

Kirk D. Denicoff

74 papers receiving 8.0k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2001 Axis I Psychiatric Comorbidity and Its Relationship to Historical Illness Variables in 288 Patients With Bipolar Disorder

Peers

Countries citing papers authored by Kirk D. Denicoff

Since Specialization

Citations

This map shows the geographic impact of Kirk D. Denicoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kirk D. Denicoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kirk D. Denicoff more than expected).

Fields of papers citing papers by Kirk D. Denicoff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kirk D. Denicoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kirk D. Denicoff. The network helps show where Kirk D. Denicoff may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Kirk D. Denicoff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kirk D. Denicoff Line = papers co-authored together Kirk D. Denicoff links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The Poor Prognosis of Childhood-Onset Bipolar Disorder Gabriele S. Leverich,Robert M. Post,Paul E. Keck,Lori L. Altshuler,Mark A. Frye,Ralph Kupka,Willem A. Nolen,Trisha Suppes,Susan L. McElroy,Heinz Grunze,Kirk D. Denicoff,Maria K.M. Moravec,David A. Luckenbaugh	2007	172
2	A 24‐week, randomized, controlled trial of adjunctive sibutramine versus topiramate in the treatment of weight gain in overweight or obese patients with bipolar disorders Susan L. McElroy,Mark A. Frye,Lori L. Altshuler,Trisha Suppes,Gerhard Hellemann,David S. Black,Jim Mintz,Ralph Kupka,Willem A. Nolen,Gabriele S. Leverich,Kirk D. Denicoff,Robert M. Post,Paul E. Keck	2007	45
3	Double-Blind, Randomized, Placebo-Controlled Trials of Ethyl-Eicosapentanoate in the Treatment of Bipolar Depression and Rapid Cycling Bipolar Disorder Paul E. Keck,Jim Mintz,Susan L. McElroy,Marlene P. Freeman,Trisha Suppes,Mark A. Frye,Lori L. Altshuler,Ralph Kupka,Willem A. Nolen,Gabriele S. Leverich,Kirk D. Denicoff,Heinz Grunze,Naihua Duan,Robert M. Post	2006	165
4	Comparison of Rapid-Cycling and Non-Rapid-Cycling Bipolar Disorder Based on Prospective Mood Ratings in 539 Outpatients Ralph Kupka,David A. Luckenbaugh,Robert M. Post,Trisha Suppes,Lori L. Altshuler,Paul E. Keck,Mark A. Frye,Kirk D. Denicoff,Heinz Grunze,Gabriele S. Leverich,Susan L. McElroy,Jörg Walden,Willem A. Nolen	2005	125
5	Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for Difficult-to-Treat depression Husseini K. Manji,Jorge A. Quiroz,Jonathan Sporn,Jennifer L. Payne,Kirk D. Denicoff,N. A. B. Gray,Carlos A. Zarate,Dennis S. Charney	2003	400
6	Psychosis in bipolar disorder: phenomenology and impact on morbidity and course of illness Paul E. Keck,Susan L. McElroy,Jennifer R. Havens,Lori L. Altshuler,Willem A. Nolen,Mark A. Frye,Trisha Suppes,Kirk D. Denicoff,Ralph Kupka,Gabrielle S Leverich,A. John Rush,Robert M. Post	2003	149
7	Impact of Antidepressant Discontinuation After Acute Bipolar Depression Remission on Rates of Depressive Relapse at 1-Year Follow-Up Lori L. Altshuler,Trisha Suppes,David S. Black,Willem A. Nolen,Paul E. Keck,Mark A. Frye,Susan L. McElroy,Ralph Kupka,Heinz Grunze,Jörg Walden,Gabrielle S Leverich,Kirk D. Denicoff,David A. Luckenbaugh,Robert M. Post	2003	180
8	Gender Differences in Prevalence, Risk, and Clinical Correlates of Alcoholism Comorbidity in Bipolar Disorder Mark A. Frye,Lori L. Altshuler,Susan L. McElroy,Trisha Suppes,Paul E. Keck,Kirk D. Denicoff,Willem A. Nolen,Ralph Kupka,Gabriele S. Leverich,Chad Pollio,Heinz Grunze,Jorge Walden,Robert M. Post	2003	153
9	Correlates of Overweight and Obesity in 644 Patients With Bipolar Disorder Susan L. McElroy,Mark A. Frye,Trisha Suppes,Dawn Dhavale,Paul E. Keck,Gabriele S. Leverich,Lori L. Altshuler,Kirk D. Denicoff,Willem A. Nolen,Ralph Kupka,Heinz Grunze,J. Walden,Robert M. Post	2002	271
10	Tiagabine in treatment refractory bipolar disorder: a clinical case series Trisha Suppes,K. Chisholm,Dawn Dhavale,Mark A. Frye,Lori L. Altshuler,Susan L. McElroy,Paul E. Keck,Willem A. Nolen,Ralph Kupka,Kirk D. Denicoff,Gabrielle S Leverich,A. John Rush,Robert M. Post	2002	48
11	Axis I Psychiatric Comorbidity and Its Relationship to Historical Illness Variables in 288 Patients With Bipolar Disorderbreakdown → S L McElroy,L L Altshuler,Trisha Suppes,P E Keck,Mark A. Frye,Kirk D. Denicoff,Willem A. Nolen,Ralph Kupka,Gabriele S. Leverich,Jennifer Rochussen,A. John Rush,Robert M. Post	2001	539
12	The Stanley Foundation Bipolar Treatment Outcome Network Gabriele S. Leverich,Willem A. Nolen,A. John Rush,Susan L. McElroy,Paul E. Keck,Kirk D. Denicoff,Trisha Suppes,Lori L. Altshuler,Ralph Kupka,Keith G. Kramlinger,Robert M. Post	2001	155
13	The Stanley Foundation Bipolar Treatment Outcome Network Trisha Suppes,Gabriele S. Leverich,Paul E. Keck,Willem A. Nolen,Kirk D. Denicoff,Lori L. Altshuler,Susan L. McElroy,A. John Rush,Ralph Kupka,Mark A. Frye,Maia Bickel,Robert M. Post	2001	406
14	Special issues in trial design and use of placebo in bipolar illness Robert M. Post,Kirk D. Denicoff,Gabriele S. Leverich	2000	13
15	Emerging trends in the treatment of rapid cycling bipolar disorder: a selected review Robert M. Post,Mark A. Frye,Kirk D. Denicoff,Gabriele S. Leverich,Robert T. Dunn,Elizabeth Osuch,Andrew M. Speer,Gabriela V. Obrocea,Kamal Jajodia	2000	33
16	The Increasing Use of Polypharmacotherapy for Refractory Mood Disorders Mark A. Frye,Terence A. Ketter,Gabriele S. Leverich,Teresa Huggins,Caprice Lantz,Kirk D. Denicoff,Robert M. Post	2000	225
17	Comparative Prophylactic Efficacy of Lithium, Carbamazepine, and the Combination in Bipolar Disorder Kirk D. Denicoff,Earlian E. Smith‐Jackson,Elizabeth R. Disney,Omar Ali,Gabriele S. Leverich,Robert M. Post	1997	221
18	New Developments in the Use of Anticonvulsants as Mood Stabilizers Robert M. Post,Terence A. Ketter,Peggy J. Pazzaglia,Mark S. George,Lauren B. Marangell,Kirk D. Denicoff	1993	14
19	Suicidal ideation in Darier's disease Kirk D. Denicoff,Zachary A. Lehman,David R. Rubinow,Peter J. Schmidt,Gary L. Peck	1990	29
20	Alternate-Day Corticosteroid Treatment, Mood and Plasma HVA in Patients with Systemic Lupus erythematosus Russell T. Joffe,Owen M. Wolkowitz,David R. Rubinow,Kirk D. Denicoff,George C. Tsokos,Stanley R. Pillemer	1988	4

About Kirk D. Denicoff

Kirk D. Denicoff is a scholar working on Psychiatry and Mental health, Biological Psychiatry and Speech and Hearing, having authored 74 papers that have together received 8.5k indexed citations. Recurring topics across this work include Bipolar Disorder and Treatment (57 papers), Electroconvulsive Therapy Studies (21 papers), Schizophrenia research and treatment (16 papers), Pharmacological Effects and Toxicity Studies (13 papers), Adolescent and Pediatric Healthcare (10 papers), Treatment of Major Depression (10 papers), Tryptophan and brain disorders (7 papers) and Epilepsy research and treatment (6 papers). The work is most often cited by research in Biological Psychiatry (1.1k citations), Psychiatry and Mental health (6.4k citations) and Behavioral Neuroscience (417 citations). Kirk D. Denicoff has collaborated with scholars based in United States, Netherlands and Czechia. Frequent co-authors include Gabriele S. Leverich, Robert M. Post, Mark A. Frye, Ralph Kupka, Willem A. Nolen, Lori L. Altshuler, Susan L. McElroy, Paul E. Keck, Trisha Suppes and A. John Rush.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact